Croyez Bioscience
Taipei, Taiwan· Est.
Taiwanese GMP‑grade mRNA and protein provider enabling rapid cell‑ and gene‑therapy research.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwanese GMP‑grade mRNA and protein provider enabling rapid cell‑ and gene‑therapy research.
OncologyImmunologyInfectious Disease
Technology Platform
High‑fidelity in‑vitro transcription and GMP‑grade lipid nanoparticle formulation for scalable mRNA and protein production.
Opportunities
Rising demand for GMP‑grade mRNA and protein reagents in cell‑therapy and vaccine development offers significant growth potential.
Risk Factors
Scaling manufacturing capacity and meeting stringent regulatory standards could limit rapid expansion.
Competitive Landscape
Competes with global CDMOs and RNA‑focused firms; differentiation lies in Taiwan‑based GMP facilities and integrated CRO services.